The Female Health Company (AMEX: FHC), the sole manufacturer and marketer of the FC1 and FC2 female condoms, provides an innovative option to women that protects against both sexually transmitted diseases and unintended pregnancy. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People’s Republic of China, South Korea and Japan, while patents are pending for FC2. For further information, visit the Company’s web site at www.femalehealth.com.
- 17 years ago
QualityStocks
The Female Health Company (AMEX: FHC)
Tags Rodman & Renshaw
Related Post
-
New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Positioned to Supply Critical Global Silver Demand from Bolivia Assets
New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, both located…
-
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
The FDA offered supportive feedback on Clene’s proposed statistical analysis plan during a recent Type…
-
Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Drives Metallurgical Testing to Unlock Santa Fe Value
Lahontan has commenced column leach testing at Santa Fe, targeting more efficient cyanide leach gold…